Premium
Missing heritability in Bloom syndrome: First report of a deep intronic variant leading to pseudo‐exon activation in the BLM gene
Author(s) -
Backers Lynn,
Parton Bram,
De Bruyne Marieke,
Tavernier Simon J.,
Van Den Bogaert Kris,
Lambrecht Bart N.,
Haerynck Filomeen,
Claes Kathleen B.M.
Publication year - 2021
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/cge.13859
Subject(s) - genetics , exon , biology , intron , gene , bloom syndrome , stop codon , exon skipping , alternative splicing , rna , helicase
Pathogenic biallelic variants in the BLM/RECQL3 gene cause a rare autosomal recessive disorder called Bloom syndrome (BS). This syndrome is characterized by severe growth delay, immunodeficiency, dermatological manifestations and a predisposition to a wide variety of cancers, often multiple and very early in life. Literature shows that the main mode of BLM inactivation is protein translation termination. We expanded the molecular spectrum of BS by reporting the first deep intronic variant causing intron exonisation. We describe a patient with a clinical phenotype of BS and a strong increase in sister chromatid exchanges (SCE), who was found to be compound heterozygous for a novel nonsense variant c.3379C>T, p.(Gln1127Ter) in exon 18 and a deep intronic variant c.3020‐258A>G in intron 15 of the BLM gene. The deep intronic variant creates a high‐quality de novo donor splice site, which leads to retention of two intron segments. Both pseudo‐exons introduce a premature stop codon into the reading frame and abolish BLM protein expression, confirmed by Western Blot analysis. These findings illustrate the role of non‐coding variation in Mendelian disorders and herewith highlight an unmet need in routine testing of Mendelian disorders, being the added value of RNA‐based approaches to provide a complete molecular diagnosis.